- Home
- GURE vs APRE Comparison
GURE vs APRE Comparison
Compare GURE & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- APRE
- Stock Information
- Founded
- GURE 2006
- APRE 2006
- Country
- GURE China
- APRE United States
- Employees
- GURE N/A
- APRE N/A
- Industry
- GURE Major Chemicals
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GURE Industrials
- APRE Health Care
- Exchange
- GURE Nasdaq
- APRE Nasdaq
- Market Cap
- GURE 8.5M
- APRE 10.0M
- IPO Year
- GURE 1992
- APRE 2019
- Fundamental
- Price
- GURE $0.68
- APRE $1.71
- Analyst Decision
- GURE
- APRE Strong Buy
- Analyst Count
- GURE 0
- APRE 2
- Target Price
- GURE N/A
- APRE $15.50
- AVG Volume (30 Days)
- GURE 2.0M
- APRE 51.7K
- Earning Date
- GURE 05-13-2025
- APRE 08-11-2025
- Dividend Yield
- GURE N/A
- APRE N/A
- EPS Growth
- GURE N/A
- APRE N/A
- EPS
- GURE N/A
- APRE N/A
- Revenue
- GURE $7,958,395.00
- APRE $1,284,475.00
- Revenue This Year
- GURE N/A
- APRE N/A
- Revenue Next Year
- GURE N/A
- APRE N/A
- P/E Ratio
- GURE N/A
- APRE N/A
- Revenue Growth
- GURE N/A
- APRE 33.27
- 52 Week Low
- GURE $0.50
- APRE $1.41
- 52 Week High
- GURE $1.65
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- GURE 50.90
- APRE 52.34
- Support Level
- GURE $0.66
- APRE $1.48
- Resistance Level
- GURE $0.99
- APRE $1.91
- Average True Range (ATR)
- GURE 0.08
- APRE 0.16
- MACD
- GURE 0.01
- APRE -0.00
- Stochastic Oscillator
- GURE 29.57
- APRE 63.14
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.